Exclusive: Mytos inks cell therapy manufacturing deals with three European biotechs news2025-09-03T07:00:17+00:00September 3rd, 2025|Endpoints News|
Amgen to expand California headquarters with new $600M R&D center news2025-09-02T16:19:01+00:00September 2nd, 2025|Endpoints News|
Genentech’s $700M North Carolina build; Telix gets CRL for imaging agent news2025-08-28T15:04:01+00:00August 28th, 2025|Endpoints News|
Lilly pauses Mounjaro orders in the UK just before raising its price news2025-08-28T10:32:52+00:00August 28th, 2025|Endpoints News|
US officials link tariffs with drug pricing talksnews2025-08-26T19:53:10+00:00August 26th, 2025|Endpoints News|
Biopharma has promised $290B+ in US manufacturing in the past six monthsnews2025-08-21T17:02:22+00:00August 21st, 2025|Endpoints News|
Trump’s ‘most favored nation’ policy will apply to EU generics news2025-08-21T16:08:20+00:00August 21st, 2025|Endpoints News|
Nucleus RadioPharma taps former FDA commissioner as CEO news2025-08-20T15:49:34+00:00August 20th, 2025|Endpoints News|
Catalent lays off 350 workers over change in demand from a ‘large customer’ news2025-08-20T11:20:59+00:00August 20th, 2025|Endpoints News|
Irish pharma exports to the US decrease after months of stockpilingnews2025-08-19T15:12:03+00:00August 19th, 2025|Endpoints News|
